Article
Concordant analysis of KRAS status in primary colon carcinoma and matched metastasis.
Anticancer research - 1 Oct 2010
Mariani Pascale, Lae Marick, Degeorges Armelle, Cacheux Wulfran, Lappartient Emmanuelle, Margogne Audrey, Pierga Jean-Yves, Girre Véronique, Mignot Laurent, Falcou Marie Christine, Salmon Rémy-Jacques, Delattre Olivier, De Cremoux Patricia
Abstract excerpt
KRAS somatic mutations are the main predictive factor for non response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer (mCRC) patients. We compared KRAS mutational status in the primary tumour and the corresponding metastases (1 to 4 sites) in 38 mCRC patients. KRAS mutatio...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
